QUTENZA (capsaicin), local analgesic patch

PAIN - Update

Opinions on drugs - Posted on Mar 29 2017

Re-assessment of the actual benefit and the improvement in actual benefit

QUTENZA is a transdermal system with Marketing Authorisation in the treatment of peripheral neuropathic pain in adults, either alone or in combination with other analgesics.
Its efficacy is limited and its use is commonly associated with painful reactions at the application site.
QUTENZA is a second-line and beyond treatment, in combination with other analgesics, in the management of local, evaluable and delimited peripheral neuropathic pain in nondiabetic adults.
It should be prescribed after consultation with a pain specialist and its use must be re-evaluated regularly due to questions relative to its long-term use (maintenance of efficacy and absence of altered perception).

Moderate	-
Insufficient

no clinical added value

Évaluation des médicaments

All our publications

My account